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Understanding of metals 
dysregulation in patients 
with systolic and diastolic 
dysfunction in ischemic heart 
disease
noman Khan1, Satwat Hashmi2, Amna Jabbar Siddiqui3, Sabiha farooq1, 
Shahid Ahmed Sami4, nageeb Basir5, Syeda Saira Bokhari5, Hasanat Sharif4, 
Sanaullah Junejo6, Hesham R. el‑Seedi7,8* & Syed Ghulam Musharraf1,3*
ischemic heart disease (iHD) is the leading cause of death and chronic disability in the world. iHD 
affects both the systolic and diastolic function of the heart which progressively leads to heart failure; 
a structural and functional impairment of filling or ejection of blood from the heart. In this study, the 
progression of systolic and diastolic dysfunction characterized according to their echocardiographic 
parameters including left ventricular ejection fraction (EF), grades of diastolic dysfunction and ratio 
between early mitral inflow velocity and mitral annular early diastolic velocity (E/eʹ), were correlated 
with differential regulation of various metals in patients sera samples (n = 62) using inductive coupled 
plasma-mass spectrometry (ICP-MS). Chromium, nickel and selenium were found significant (p < 0.05) 
in patients having EF < 45% compared with EF > 45%. In patients with systolic dysfunction (EF < 45%), 
the level of selenium was decreased while the level of chromium and nickel was increased compared 
to patients with EF > 45%. Selenium level was also decreased significantly (p < 0.05) in grade 1A and 
2 patients that are considered as higher grades of diastole dysfunction in comparison to grade 0–1. 
Overall, selenium deficiency was identified in both systolic and diastolic dysfunctions of IHD patients 
corresponding to the progression of disease that could be related to many metabolic and translational 
pathways specifically which involve selenoproteins.
Cardiovascular diseases (CVDs) are the leading cause of death  worldwide1. An estimated 17.9 million people died 
from CVDs in 2015, representing 31% of all global deaths. Ischemic heart disease (IHD) account for the majority 
of the cases of health lost to CVDs. There are large number of prevalent cases of IHD making it the leading cause 
of chronic  disability1,2. The most common cause of IHD is atherosclerosis which is a chronic inflammatory pro-
cess represented by highly specific cellular and molecular  responses3. IHD affects both the systolic and diastolic 
function of the heart which progressively leads to heart failure; a structural and functional impairment of filling 
or ejection of blood from the  heart4. Despite advances in the current treatment plans, heart failure remains one 
of the major health care issues of the world not only due to its increasing prevalence but also health care  costs5.
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Development of high-throughput technologies for the generation of ‘omics data’ have been at the forefront 
to understand the development of  disease6. Metallomics, an emerging branch of omics, deals with a comprehen-
sive analysis of all the metals and metalloid species within a cell or  tissue7,8. It is an important field enabling to 
understand the relationship between metals and their biological and physiological functions, identification and 
quantification of these trace elements in association with the disease diagnosis and progression.
Few studies have reported the quantification of specific metals in whole blood and serum samples of ischemic 
heart  disease9–12. However, these studies did not involve any clinical correlation with metal concentrations. 
In our study, we employed a correlation of metallomic analysis with patients categorized on the basis of their 
systole function i.e. EF < 45% and EF > 45%. Development of diastolic dysfunction was also studied using other 
echocardiographic parameters that are grades of diastolic dysfunction (0–1, 1A and 2) and ratio between early 
mitral inflow velocity and mitral annular early diastolic velocity, E/eʹ (< 8, 9–15 and > 15) of IHD patients in order 
to gain insight into metallomic status of patients in understanding of disease progression.
Material and methods
Patient’s selection and classification. This study was recruited IHD patient, which were admitted for 
coronary artery bypass grafting (CABG) in South City and Aga Khan University Hospital of Karachi. The sam-
ples were collected from both hospitals after obtaining written informed consent from the patients. The ethical 
approval boards of South City, Aga Khan University Hospital and Institutional Review Board (IRB) of ICCBS 
approved the current study. All methods were performed in accordance with the relevant guideline and regula-
tions approved by the committee. The assessment of systolic and diastolic function with left ventricular (LV) 
morphology was conducted by 2D Doppler echocardiography according to the guideline of ASE 2009.
Patients were classified into different categories according to the ejection fraction (EF < 45% and EF > 45%) 
and diastolic dysfunction by E/e values (> 15, 9–15 and < 8) and grades (0–1, 1A and 2) as depicted in Table 1. It 
was observed that the corrected p-values are significant for few patients` basic characteristics. Hence an unsuper-
vised learning algorithm was applied on the concentrations of metals with reference to the age, weight, BMI and 
blood pressure (both systole and diastole). The results in the form of PCA score plot are shown in Supplementary 
Figure S1. No significant separation trend/grouping was observed in all plots. Dysfunction of  diastole13,14 were 
categorized with different grades include impaired relaxation of LV with or without increased in filling pressure 
indicated by grade I or IA, moderate increased in LV filling pressure is linked with the pseudo-normalization of 
LV i.e. grade II and increased in filling pressure markedly is the restrictive LV filling denoted as grade III. Patients 
with malignancy, constrictive pericarditis and infiltrative, established pulmonary disease, renal insufficiency, 
moderate to severe valvular disease, hypertrophic cardiomyopathies and metabolic bone diseases were omitted 
Table 1.  Experimental subject description of healthy and ischemic heart disease (diastolic and systolic) of 
serum samples. µ mean, σ standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic 
blood pressure, BUN blood urea nitrogen.
Patient characteristics Disease Healthy p-value
Number of samples 62 55 –
Gender (male/female) 54/8 44/11 –
Age male (years; µ ± σ) 58.90 ± 8.34 31.3 ± 6.41 2 × 10–33
Age female (years; µ ± σ) 58.12 ± 9.51 30.18 ± 9.03 3 × 10–5
Height (cm) 163.80 ± 8.91 167.32 ± 7.95 0.0649
Body weight (Kg) 72.41 ± 11.94 65.49 ± 6.99 8 × 10–5
BMI (Kg/m2) 26.66 ± 4.83 23.59 ± 3.64 0.0007
SBP (mm Hg) 129.46 ± 18.60 112.91 ± 10.48 1 × 10–7




Chest pain/non-chest pain 48/14 0/55
Current smoker/non-smokers 11/51 0/55
Hypercholesterolemia/non-hypercholesterolemia 6/56 0/55
Echocardiographic parameters
Ejection fraction (< 45%/ > 45%) 12/50 –
Grades 0–1/1A and 2) 45/4/and 5 –
E/e′ (< 8/9–15 and > 15) 12/33 and 7 –
Biochemical parameters
Creatinine (mg/dl) 0.99 ± 0.26 –
BUN (mg/dl) 17.74 ± 7.85 –
Random blood glucose (mg/dl) 183.67 ± 64.81 –
Fasting blood glucose (mg/dl) 164.96 ± 57.98 –
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from the study It is possible that the screened biochemical parameters are influenced by the cardiac dysfunction 
either systole or diastole. Therefore, we tested this hypothesis and results are incorporated in Supplementary 
Table 1. It was clearly observed from the table results that the biochemical parameters of the recruited patients 
are not statistically significant different with reference to the ejection fraction values and grades.
Healthy control subjects (n = 55) were selected based on the following criteria; subjects were recruited ran-
domly from the community if they had no symptoms suggestive of IHD, no past history of IHD or any proven 
past myocardial infarction or coronary intervention and without any symptoms of functional class I.
Sample collection and processing. BD vacutainer tube based on gel (Cat # 367381), was used to transfer 
4 ml of blood, which was collected from the subject under investigation. After standing the BD vacutainer tube 
for 10–15 min, serum samples were separated by using centrifugation at 2000 rpm for 10 min. After centrifu-
gation, aliquots of serum were transferred into locking Eppendorf tube. Serum samples were kept in freezer 
at − 80 °C until sample analysis.
Reagents and standards. During the experimental work, filtered and extremely pure deionized water 
was obtained from the water filtration and purification system (Thermo scientific, MA USA). Analytical grade 
reagent (AR, ACS), 70% concentrated  HNO3 (RCI Labscan Ltd, Bangkok, Thailand) was used for analysis after 
purification by NanoPure Acid purification system (Nanonex, USA). Trace metal grade ≥ 30% concentrated 
 H2O2 was acquired from Merck KGaA company (Darmstadt, Germany). The tuning solution with 1 µg/L con-
centration of Mg, Li, Tl, Y, Co and Ce in 2%  HNO3, multi-element calibration solution 2A (Part Number: 8500-
6940) with confirmed concentration of 10 µg/mL of each element and, internal standard of 100 µg/mL (Tb, Rh, 
Ge, Lu, Ir, Bi, and Sc) were bought from Agilent Technologies (Santa Clara, CA, USA). The optimization of ICP-
MS parameter was carried out by using tuning solution, before the start of analysis. All cleaned glassware and 
polypropylene bottles were immersed in 10% (v/v)  HNO3 reagent for overnight. After that each apparatus was 
washed with ultra-pure water three times and kept in laminar-flow hood (Airstream ESCO, Singapore) to dry. 
The air contamination was prevented by performing experiment in clean hood and working table.
preparation of standard solutions. Matrix solution prepared as 5% nitric acid was used to prepare cali-
bration standards for 16 elements. The 100 µg/L solution of internal standard was made in matrix solution, from 
the prepared stock solution. Sixteen points calibration curves were prepared in the range of 0.0076–1,000 µg/L 
of each metal using 5%  HNO3 as matrix. A blank was also prepared with same matrix and no metal added. The 
measurement of sensitivity was done by checking the slope of regression equation. The standard solution was 
used to validate the current study by calculating correlation coefficients, LOD and LOQ.
preparation of the standard reference material. The developed method was validated by measuring 
precision and accuracy of the result obtained from trace metal Seronorm serum L-1 (Sero, Billingstad, Norway). 
The complete procedure for preparation of certified reference material (CRM) was followed as given in the pro-
tocol of manufacturer. For preparation, 3 mL of sterile deionized water was added to dissolve the content of vial 
by rolling for 30 min so that all the content is mixed completely. The content was transferred to screw cap plastic 
tube and diluted with sterile deionized water. Each trace and ultra-trace element were analysed in triplicate in 
diluted CRM samples by ICP-MS.
Sample preparation for icp‑MS. The digestion of serum samples were carried out in pressure sealed 
microwave system with 64MG5-T64 rotor (Anton Paar GmbH, Austria). It was equipped with high performance 
pressure released system. The program with Multiwave ECO software (version 1.51), was setup in the microwave 
system. The single time useable screw cap (13–425, Wheaton 15 × 45 mm) and polytetrafloroethylene (PTFE) lip 
seal tube were used as standard apparatus. For digestion, serum sample equivalent to 50 µL aliquot was added in 
the MG5 vials (Anton Paar, Hungary), where 50 µL of ≥ 30%  H2O2 and 150 µL of 70%  HNO3 were mixed, kept 
in laminar fuming hood for 15 min so that fumes were evolve from the vials. Then, vials were sealed with the 
PTFE lip and screw cap. After that sealed vials containing serum samples were placed and digested in two steps 
by adjusting same parameters in Anton Paar microwave system with same ramp (10.0 min), hold (30), fan (1), 
power (850), stir rate (medium) but temperature set 90 °C in step 1 and 150 °C in step 2. All MG5 vials were kept 
in laminar hood and wait until all samples were cooled at room temperature, as digestion process completed. 
The vials were sealed with septum so that pressure of gas released by penetrating steal pin in septum then, the 
resultant samples were took into 15 mL of autosampler polypropylene tubes and deionized water were used to 
dilute samples upto 3 mL. All the samples were analysed in triplicate for every element. Matrix correction was 
done by using internal standard solution, to check the accuracy of ICP-MS results.
Inductive coupled plasma–mass spectrometry (ICP-MS) analysis. The quantification of chosen ele-
ment was carried by Agilent 7,700 × ICP-MS system (Santa Clara, CA USA). The decontamination was removed 
from ICP-MS after each sample analysis by using washing solution contains 0.1% HCl, 2%  HNO3 and ultra-pure 
water. The workstation used for the operation of ICP-MS data is Mass Hunter software. ICP-MS parameter are 
given in the Supplementary Table 2.
Statistical analysis. The chemometric analysis was done in multiple steps by Mass Profiler Professional 
(MPP), which were bought Agilent technologies (Santa Clara, CA, USA) with complete licenced. The absolute 
abundance was adjusted with 10,000 counts for filtration process. The normalization of data was carried out by 
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external scalar to allocate the values for each sample particularly scale up and down. The selection of baseline i.e. 
Z transform, is important to treat all components equally, whatever their intensity.
Statistical analyses were performed in-between healthy and ischemic heart disease patient samples; character-
ized by systolic dysfunction by ejection fraction < 45% and > 45%, and diastolic dysfunction by grades and E/eʹ. 
Unpaired t test was used for statistical analysis of two groups while ANOVA was employed for more than two 
groups’ analyses. p-value was calculated by Asymptotic computation method and Benjamini–Hochberg FDR 
was used for multiple test corrections. All variables with p values < 0.05 and fold change > 1.5 will be considered 
as significant variables throughout the manuscript.
Multivariate data analyses including unsupervised principal component analysis (PCA) (shows an overview 
and outlier behaviour) and supervised partial least squares discriminant analysis (PLS-DA) and orthogonal par-
tial least squares discriminant analysis (OPLSDA) were performed on processed data by SIMCA MKS Umetrics 
AB (version 14.1) software.
Method validation and data quality assessment. Linear calibration curve was obtained in the con-
centration range of 0.0076–1,000 µg/L for every element. The least-square regression method was used to plot 
the data of counts per second (cps) against the measured concentrations. In the validity of the quantification 
method was evaluated by performing various parameters such as correlation coefficients  (R2), limit of quantifi-
cation (LOQ) and limit of detection (LOD). The excellent linear relationship was obtained from the calibration 
curve (n = 3) with correlation coefficients  (R2) between 0.993 and 1.000. LOQ and LOD was calculated using 
equation LOD = 3.3σ/S and LOQ = 10σ/S, where (σ) standard deviation of residual a regression line and (S) slope 
for each element. LOD and LOQ were found for all selected element in the range of 0.002–9.551 µg  L−1 and 
0.006–28.941 µg  L−1 respectively. Supplementary Table 3 compiled the regression equation,  R2, LOD and LOQ 
of each element.
To check the precision and accuracy for the developed method, Seronorm trace elements serum L-1 was used 
as reference standard material (CRM) for trace metal analysis in bio samples. It was found that all observed values 
agree with the certified values with nonsignificant variance between them. The % recovery of selected element 
was varied between 81.879 and 113.779, which are given in Supplementary Table 4.
For the assessment and validation of any analytical technique, it is necessary to perform spike recovery 
procedure. The analyte detection was monitored by checking the variation between the diluent used to prepare 
the sample and standard solution. The spike recovery test was also performed in real serum samples of two 
concentration levels for each element, to check the reliability and precisions (RSD, %) of our method. Mostly, 
the precision was found below 10%. The following relationship used to measure the precision of the method, 
Precision (RSD, %) = [standard deviation (SD)/CM] 100, where CM for measured concentration and SD means 
standard deviation. For serum samples, the coefficient of variation (% RSD) was obtained from 0.052 to 7.580 
as shown in Supplementary Table 5. Thus, our method, is sensitive, accurate with good precision and can be 
employed for the routine metals analysis in biological samples.
compliance with ethical standards. All procedures performed in studies involving human participants 
were in accordance with the ethical standards of the institutional and/or national research committee and with 
the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Results
Metallomic fingerprinting of serum for IHD patients and healthy subjects. ICP-MS analysis of 
serum samples for IHD patients and healthy subjects was performed for a total of 16 elements. Using absolute 
concentrations of elements, nine out of sixteen were found to be significantly different (p < 0.05) up regulated 
or down regulated between serum of healthy subjects and IHD patients (Table 2). Four elements including sele-
nium, lithium, aluminum, copper were down regulated and five element including zinc, silver, arsenic, cadmium 
and manganese up regulated in serum of IHD patients in comparison to healthy controls.
Based on the normalized concentration of elements, a clear trend of separation between IHD patient and 
healthy subjects was observed in PCA score plot (Fig. 1A). The first component at x-axis gave the value of  R2X 
Table 2.  List of elements in serum of IHD patients that are significantly different from serum of normal 
healthy subjects.
Elements p (Corr) Log FC (SR IHD vs SR Healthy) Regulation (SR IHD vs SR Healthy)
7 Li 2.91 × 10–13 − 1.18567 Down
78 Se 7.11 × 10–15 − 0.76438 Down
27 Al 8.00 × 10–04 − 0.49217 Down
63 Cu 0.001468 − 0.41605 Down
55 Mn 0.015824 0.227213 Up
66 Zn 1.05 × 10–07 0.785 Up
75 As 2.27 × 10–05 0.447256 Up
107 Ag 8.76 × 10–05 0.392908 Up
111 Cd 0.011826 0.125726 Up
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0.263 while the second component is 0.169. Confidence limit of 95% from Hotelling’s T2-test resulted in appear-
ance of few outliers, which were further removed before discriminant analyses. Variations of few samples were 
resulted in their PCA scores equivalent to the values that are near to the opposite group, but did not found any 
clinical correlation among these samples.
Using the normalized concentrations of nine significant metals for class discrimination analysis, it was found 
that healthy subjected were clearly separated from IHD patients as shown in the 3D score plot of PLSDA (Fig. 1B). 
The number of patients, which were correctly predicted as true positives, was used to calculate the sensitivity; 
while the number of healthy, which were correctly predicted as true negative, was used to calculate the specificity 
for the constructed model. The specificity and sensitivity of the constructed model was obtained as 93.6% and 
87.3%, respectively with 90.6% classification rate (Supplementary Table 6).
Addition of another orthogonal projection to the above model (Fig. 1C) did not affect the results showing 
the similar sensitivity and specificity of OPLS-DA model (Supplementary Table 6). ROC plot (Supplementary 
Fig. 2) and permutation (Supplementary Fig. 3) of obtained OPLS-DA model showed good area under the curve 
and lesser difference between goodness of fit and predictive ability of model.
The loading plot variables were arranged according to their performance for discrimination among the 
groups from the validated OPLS-DA model. Figure 1D showed that selenium with highest VIP value is mainly 
responsible for group separation.
Metallomic fingerprinting of serum for IHD patients with systolic dysfunction (Ejection frac‑
tion (EF) < 45% and EF > 45%). At the second stage of this study, serum samples of IHD patients were 
further categorized on the basis of systolic dysfunction. For this purpose, IHD patients were divided into two 
groups that are, EF < 45% and EF > 45%. Using absolute concentrations of elements, three out of sixteen were 
found to be significantly different (p < 0.05) (Table 3). Selenium is the only element down regulated in group of 
Figure 1.  Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot 
colored as a function of VIP of serum (SR) from healthy (green) and ischemic heart disease (IHD) (blue).
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patients with EF < 45 and chromium and nickel were found to be up regulated in patients with EF < 45 in com-
parison to EF > 45.
Based on the normalized concentration of elements, PCA score plot in Fig. 2A did not show clear separation 
on the basis of ejection fraction. However, at 95% confidence limit from Hotelling`s T2-test resulted in appear-
ance of fewer outliers as compared to healthy and IHD patient samples. The first component at x-axis gave more 
variance with the value of  R2X 0.369 while the second component is 0.121.
For class discrimination, three significant metals were used to perform PLSDA as shown in Fig. 2B. It was 
found that 3D-PLSDA plot of these metals did not show clear trend of separation in IHD patient with EF > 45% 
and < 45%. Sensitivity was found to be 98% and specificity was 16.6%, with 82.3% classification rate (Supplemen-
tary Table 7). Addition of another orthogonal projection to the above model (Fig. 2C) did not affect the sensitivity 
and specificity of OPLS-DA model too much (Supplementary Table 7). The reason behind low specificity of the 
models is clustering of few samples with EF > 45% towards the samples with EF < 45%. The loading plot variables 
were arranged according to their performance for discrimination among the groups from the validated OPLS-DA 
model. Figure 2D showed that selenium is mainly responsible for group separation.
Table 3.  List of up-regulated and down-regulated elements in preserved EF > 45% and reduced EF < 45% of 
systolic dysfunctions.
Elements p (Corr) Log FC (SR rEF < 45% vs SR pEF > 45%) Regulation (SR rEF < 45% vs SR pEF > 45%)
52 Cr 0.049478 0.69644 Up
60 Ni 0.049478 0.471092 Up
78 Se 0.030034 − 0.39566 Down
Figure 2.  Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot of 
serum with preserved EF > 45% (green) and reduced EF < 45% (blue) of systolic dysfunctions.
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Metallomic fingerprinting of serum for IHD patients with diastolic dysfunction. The IHD 
patients in this study had diastolic dysfunction with grade 1, 1A and 2. Statistical significance analysis (ANOVA) 
resulted in only one significant metal that is selenium; which was down regulated in serum of diastolic dysfunc-
tion grade 1A and grade 2 as compared to grade 0–1 (Table 4). PCA showed no separation of groups and only 
one outlier. This could possibly due to less number of samples in higher grades (Fig. 3A). PLSDA and OPLSDA 
model (Fig. 3B,C, respectively) were also produce and it shows serum diastolic dysfunction grades were clearly 
separated and differentiated with each other after orthogonal projection. However, the sensitivity and specificity 
of the model are 100% and 11%, respectively with 85.2% classification rate (Supplementary Table 7). Due to less 
number of samples at higher grades of disease, it is unable to generate a specific model as it required. The vari-
able loading plot from the validated OPLS-DA model showed lithium and selenium are mainly responsible for 
group separation (Fig. 3D).
Another parameter for measuring diastolic dysfunction by echocardiography includes E/eʹ. The E/eʹ is used 
as non-invasive surrogate which indicates increased LV filling pressure, for diastolic  disfunction15. It is measured 
as the ratio of early mitral inflow and mitral annular early diastolic velocity. The E/e′ of < 8 represents the normal 
heart filing pressure and increased in the LV filling pressured represented by E/e′ > 15. Another range of E/e′ 
i.e. 9–15 represents borderline and required additional measurements regarding the confirmation of increased 
filling pressure.
Table 4.  list of up-regulated and down regulated elements in serum Grade 0–1, Grade 1A and Grade 2 of 
dystolic dysfunctions.
Element p (Corr)
Log FC (SR Grade 1A vs SR Grade 
0–1)
Regulation (SR Grade 1A vs SR 
Grade 0–1)
Log FC (SR Grade 2 vs SR Grade 
0–1)
Regulation (SR Grade 2 vs SR 
Grade 0–1)
78 Se 1.86 × 10–08 − 2.1666555 Down − 0.5374251 Down
Figure 3.  Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot of 
serum with Grade 0–1 (green), Grade 1A (blue) and Grade 2 (red) of diastolic dysfunctions.
8
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:13948  | https://doi.org/10.1038/s41598-020-70733-4
www.nature.com/scientificreports/
PCA shows no clear separation trend due to the overlapping of samples between groups of IHD patients with 
different values of E/e′ (Fig. 4A). Significant overlapping is also found in PLSDA model with 33.3% sensitivity and 
82.5% specificity (Fig. 4B and Supplementary Table 7). However, OPLSD model (Fig. 4C) showed some trend of 
discrimination between the three groups. Lithium, selenium and calcium are most important elements, which is 
related to group differentiation according to the VIP values (Fig. 4D). There is no statistically significant element 
was found on the basis of E/e′ values.
Discussion
Our study demonstrated the snap shot of major metals that are differentially regulated in IHD patients in a single 
canvas using metallomic approach. At first our results described the comparison of serum of IHD patients and 
healthy subjects. Then the differentially regulated metals in IHD patients with systolic dysfunction grouped in 
EF > 45 as patients with normal systolic function and EF < 45, as patients with systolic dysfunction were pre-
sented. We further analyzed IHD patient based on the different grades of diastolic dysfunction and also looked 
with respect to their E/e′ ratio, that is the most sensitive indicator for the measurement of higher LV pressures.
Our study has shown that selenium, lithium, aluminum and copper were down regulated in serum of IHD 
patients compared to healthy subjects, whereas, zinc, silver, arsenic, cadmium and manganese were up regulated 
in IHD patients. In all of the above mentioned metals, selenium was mainly responsible for group separation.
Previous reports on atherosclerosis observed that the concentration of copper and zinc were significantly 
lower in patient when compared with healthy, however no correlation was found between the groups and disease 
 severity16. Another study suggested the risk factors for acute coronary syndrome might be due to the deficiencies 
of copper, zinc and  selenium17.
The trace elements identified in our study as well as in previous work play important roles in cellular and 
molecular processes in  biology18. Copper regulates oxidative free radical and its deficiency leads to increased risk 
of oxidative  damage19 seen as lipoprotein  oxidation20, decreased cytochrome C oxidase  activity21, myofibrillar 
disarray and mitochondrial  impairment22. Zinc acts as an  antioxidant23 and its deficiency has been linked to 
lipid  peroxidation24 as well as contractile dysfunction in the  heart25. Other studies have hinted at the possibility 
Figure 4.  Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot of 
serum with E/eʹ < 8 (green), E/eʹ 9–15 (blue) and E/eʹ > 15 (red) of diastolic dysfunction.
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that zinc may increase the risk of  IHD26. Our results show higher levels of Zn in IHD patients. Serum zinc levels 
have been shown to correlate with intake of various medications as well as nutritional status, as it has an indirect 
absorption relationship with copper in IHD  patients26,27.
Manganese is part of superoxide dismutase and adenylyl cyclase, the two antioxidant enzymes fighting oxi-
dative stress in the body. Mice without the manganese-superoxide dismutase gene die at day 10 of birth due to 
dilated  cardiomyopathy28, but its levels were found to be higher in heart failure  patients29. Cadmium is a non-
essential toxic metal found in tobacco, air and food. There is growing evidence that increased levels are associated 
with high IHD disease  risk30.
Selenium, an essential trace element, has gathered attention in terms to its importance in the optimal func-
tioning of the cardiovascular system. Selenium mediates its effect through incorporation through various sele-
noproteins. It has wide ranging effects from regulation of inflammatory response and immune cell activity to 
control of migration, adherence and phagocytosis of  leucocytes31,32. Its major contribution, however, is its role 
in the antioxidant defense mechanism of the body. Selenium is a crucial component of the antioxidant enzyme 
glutathione peroxidase and thioredoxin reductases. Thioredoxin reductase reproduce the thioredoxin and thus 
balancing the redox mechanism of the cell, while glutathione peroxidases perform protective mechanism of the 
cell from DNA damage and/or lipoprotein by detoxifying the intracellular hydrogen  peroxide33. The platelet 
aggregation would increase by its deficiency, through the mechanism of free lipid peroxides on prostacyclin 
synthase and thromboxane  A34.
It has been postulated that cardiovascular pathologies and low intake of selenium were associated with each 
other and might be due to the increased in the oxidative stress and its sequelae. Selenium deficiency has been 
linked historically to Keshan disease, named after a Chinese town where a rapidly progressive cardiomyopathy 
with degenerative changes and extensive fibrosis in the heart was reported almost 80 years  ago35. First evidence 
that selenium contributed to the antioxidant defense mechanism in cardiomyocytes came from Lu et al.36 after 
which a series of animal experiments showed that myocardial injury increased by the deficiency of selenium with 
lipid peroxidation after myocardial ischemia–reperfusion  injuries37,38. Experiments have shown convincingly 
that decreased glutathione peroxidase activity measured in the blood and cardiomyocytes was responsible for 
this  injury39. There have been many reports in literature that selenium is associated with risk of  IHD40,41. Serum 
selenium was found to be inversely associated with age, smoking, alcohol intake Serum selenium was found to 
be positively associated with HDL cholesterol, blood hemoglobin, total serum cholesterol and  adiposity42, and 
inversely associated with alcohol consumption, smoking and  age43. Selenium plays vital role in protecting car-
diovascular system by forming inactive complexes with metals, such as mercury, cadmium and arsenic which 
were associated with atherogenesis and resist oxidative damage induced by these  metals44 and its deficiency has 
particularly been linked to the degree of myocardial  necrosis45.
Our study found selenium to be the only element up regulated in patients with EF > 45 as compared to 
EF < 45. Among patients with IHD, selenium deficiency does correspond to the degree of systolic dysfunction 
of the heart. Selenium has also come up as an important element in IHD patients as it was also decreases with 
disease severity in terms of grades of diastolic dysfunction. The patients were grouped according to their diastolic 
function states into grades, without taking into account their EF status, so our results depict selenium deficiency 
associated with diastolic dysfunction grade 1A and 2 in comparison to grade 0–1. Our results hint at the common 
pathophysiological process that play in the development of systolic and diastolic dysfunction of the heart which 
is associated with selenium deficiency among other trace element perturbations.
conclusion
In conclusion, IHD patients with systolic and diastolic dysfunction of the heart showed disturbed trace element 
profile. Selenium deficiency has been shown to be associated with systolic and diastolic dysfunction of the heart 
in IHD patients. The phenomena of pathophysiological mechanism involved in the dysfunction of systole and 
diastole of IHD patients was approached using metallomic fingerprinting of these patients. However, combin-
ing these results with metalloproteins analysis in atrial tissue and other biofluids will clear the mechanism in 
deep. The size of samples in our study is small as one of the limitation and also did not include the high grades 
of diastolic dysfunction such as Grade III and IV.
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